{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:53:09Z","timestamp":1772891589986,"version":"3.50.1"},"reference-count":30,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,9,15]]},"DOI":"10.2169\/internalmedicine.4985-24","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T18:14:42Z","timestamp":1741976082000},"page":"2764-2768","source":"Crossref","is-referenced-by-count":3,"title":["Multiple Myeloma in a Patient with Birt-Hogg-Dub\u00e9 Syndrome"],"prefix":"10.2169","volume":"64","author":[{"given":"Fumiaki","family":"Matsumura","sequence":"first","affiliation":[{"name":"Department of Hematology, University of Tsukuba Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuhiro","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Hematology, Institute of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirayasu","family":"Kai","sequence":"additional","affiliation":[{"name":"Ibaraki Clinical Education and Training Center, Institute of Medicine, University of Tsukuba Hospital, Japan"},{"name":"Ibaraki Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Usui","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Institute of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunio","family":"Kawanishi","sequence":"additional","affiliation":[{"name":"Department of Experimental Pathology, Institute of Medicine, University of Tsukuba, Japan"},{"name":"Department of Anatomy, Showa Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Institute of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kantaro","family":"Ishitsuka","sequence":"additional","affiliation":[{"name":"Department of Hematology, University of Tsukuba Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Makishima","sequence":"additional","affiliation":[{"name":"Department of Hematology, University of Tsukuba Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakurako","family":"Suma","sequence":"additional","affiliation":[{"name":"Department of Hematology, University of Tsukuba Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Department of Hematology, University of Tsukuba Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayasu","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Hematology, Institute of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Kurita","sequence":"additional","affiliation":[{"name":"Department of Hematology, Institute of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichiro","family":"Hattori","sequence":"additional","affiliation":[{"name":"Department of Hematology, Institute of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhito","family":"Suehara","sequence":"additional","affiliation":[{"name":"Department of Hematology, Institute of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Nishikii","sequence":"additional","affiliation":[{"name":"Department of Hematology, Institute of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoshi","family":"Obara","sequence":"additional","affiliation":[{"name":"Department of Hematology, Institute of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joichi","family":"Usui","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Institute of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Matsubara","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Institute of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Yamagata","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Institute of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamiko","family":"Sakata-Yanagimoto","sequence":"additional","affiliation":[{"name":"Department of Hematology, Institute of Medicine, University of Tsukuba, Japan"},{"name":"Division of Advanced Hemato-Oncology, Transborder Medical Research Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Birt AR, Hogg GR, Dub\u00e9 WJ. Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch Dermatol 113: 1674-1677, 1977.","DOI":"10.1001\/archderm.1977.01640120042005"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Nickerson ML, Warren MB, Toro JR, et al. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dub\u00e9 syndrome. Cancer Cell 2: 157-164, 2002.","DOI":"10.1016\/S1535-6108(02)00104-6"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Mota-Burgos A, Acosta EH, M\u00e1rquez FV, Mendiola M, Herrera-Ceballos E. Birt-Hogg-Dub\u00e9 syndrome in a patient with melanoma and a novel mutation in the <i>FCLN<\/i> gene. Int J Dermatol 52: 323-326, 2013.","DOI":"10.1111\/j.1365-4632.2012.05742.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Chung JY, Ramos-Caro FA, Beers B, Ford MJ, Flowers F. Multiple lipomas, angiolipomas, and parathyroid adenomas in a patient with Birt-Hogg-Dube syndrome. Int J Dermatol 35: 365-367, 1996.","DOI":"10.1111\/j.1365-4362.1996.tb03642.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Liu V, Kwan T, Page EH. Parotid oncocytoma in the Birt-Hogg-Dub\u00e9 syndrome. J Am Acad Dermatol 43: 1120-1122, 2000.","DOI":"10.1067\/mjd.2000.109288"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kurata K, Matsumoto H, Jimbo N, et al. Lymphoplasmacytic lymphoma in a patient with Birt-Hogg-Dub\u00e9 syndrome. Int J Hematol 112: 864-870, 2020.","DOI":"10.1007\/s12185-020-02970-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ramirez Reyes JMJ, Cuesta R, Pause A. Folliculin: a regulator of transcription through AMPK and mTOR signaling pathways. Front Cell Dev Biol 9: 667311, 2021.","DOI":"10.3389\/fcell.2021.667311"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Wang T, Yang Y, Feng H, et al. Concurrent germline and somatic mutations in FLCN and preliminary exploration of its function: a case report. Front Oncol 12: 877470, 2022.","DOI":"10.3389\/fonc.2022.877470"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Gosis BS, Wada S, Thorsheim C, et al. Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1. Science 376: eabf8271, 2022.","DOI":"10.1126\/science.abf8271"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Baba M, Keller JR, Sun HW, et al. The folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dub\u00e9 syndrome is required for murine B-cell development. Blood 120: 1254-1261, 2012.","DOI":"10.1182\/blood-2012-02-410407"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Park H, Staehling K, Tsang M, et al. Disruption of <i>Fnip1<\/i> reveals a metabolic checkpoint controlling B lymphocyte development. Immunity 36: 769-781, 2012.","DOI":"10.1016\/j.immuni.2012.02.019"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ram\u00edrez JA, Iwata T, Park H, et al. Folliculin interacting protein 1 maintains metabolic homeostasis during B cell development by modulating AMPK, mTORC1, and TFE3. J Immunol 203: 2899-2908, 2019.","DOI":"10.4049\/jimmunol.1900395"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Yang G, Buhrlage SJ, Tan L, et al. HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib. Blood 127: 3237-3252, 2016.","DOI":"10.1182\/blood-2016-01-695098"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Liu W, Huang Y, Wang D, et al. MPDZ as a novel epigenetic silenced tumor suppressor inhibits growth and progression of lung cancer through the Hippo-YAP pathway. Oncogene 40: 4468-4485, 2021.","DOI":"10.1038\/s41388-021-01857-8"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Xie C, Zhong L, Luo J, et al. Identification of mutation gene prognostic biomarker in multiple myeloma through gene panel exome sequencing and transcriptome analysis in Chinese population. Comput Biol Med 163: 107224, 2023.","DOI":"10.1016\/j.compbiomed.2023.107224"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Zheng B, Sun W, Yi K, et al. Integrated transcriptomic analysis reveals a distinctive role of YAP1 in extramedullary invasion and therapeutic sensitivity of multiple myeloma. Front Oncol 11: 787814, 2021.","DOI":"10.3389\/fonc.2021.787814"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Cottini F, Hideshima T, Xu C, et al. Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers. Nat Med 20: 599-606, 2014.","DOI":"10.1038\/nm.3562"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Grieve S, Wajnberg G, Lees M, et al. TAZ functions as a tumor suppressor in multiple myeloma by downregulating MYC. Blood Adv 3: 3613-3625, 2019.","DOI":"10.1182\/bloodadvances.2019000374"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Maruyama J, Inami K, Michishita F, et al. Novel YAP1 activator, identified by transcription-based functional screen, limits multiple myeloma growth. Mol Cancer Res 16: 197-211, 2018.","DOI":"10.1158\/1541-7786.MCR-17-0382"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Hasumi H, Furuya M, Tatsuno K, et al. BHD-associated kidney cancer exhibits unique molecular characteristics and a wide variety of variants in chromatin remodeling genes. Hum Mol Genet 27: 2712-2724, 2018.","DOI":"10.1093\/hmg\/ddy181"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Paigen K, Petkov PM. PRDM9 and its role in genetic recombination. Trends Genet 34: 291-300, 2018.","DOI":"10.1016\/j.tig.2017.12.017"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Bolli N, Biancon G, Moarii M, et al. Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups. Leukemia 32: 2604-2616, 2018.","DOI":"10.1038\/s41375-018-0037-9"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kelly T, B\u00f8rset M, Abe E, Gaddy-Kurten D, Sanderson RD. Matrix metalloproteinases in multiple myeloma. Leuk Lymphoma 37: 273-281, 2000.","DOI":"10.3109\/10428190009089428"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Saveanu L, van Endert P. The role of insulin-regulated aminopeptidase in MHC class I antigen presentation. Front Immunol 3: 57, 2012.","DOI":"10.3389\/fimmu.2012.00057"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Miettinen JJ, Kumari R, Traustadottir GA, et al. Aminopeptidase expression in multiple myeloma associates with disease progression and sensitivity to melflufen. Cancers (Basel) 13: 1527, 2021.","DOI":"10.3390\/cancers13071527"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Sattler EC, Syunyaeva Z, Reithmair M, Dempke W, Steinlein OK. Colorectal cancer risk in families with Birt-Hogg-Dub\u00e9 syndrome increased. Eur J Cancer 151: 168-174, 2021.","DOI":"10.1016\/j.ejca.2021.04.013"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Khoo SK, Giraud S, Kahnoski K, et al. Clinical and genetic studies of Birt-Hogg-Dub\u00e9 syndrome. J Med Genet 39: 906-912, 2002.","DOI":"10.1136\/jmg.39.12.906"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Nahorski MS, Lim DH, Martin L, et al. Investigation of the Birt-Hogg-Dub\u00e9 tumour suppressor gene (<i>FLCN<\/i>) in familial and sporadic colorectal cancer. J Med Genet 47: 385-390, 2010.","DOI":"10.1136\/jmg.2009.073304"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. van de Beek I, Glykofridis IE, Wolthuis RMF, et al. No evidence for increased prevalence of colorectal carcinoma in 399 Dutch patients with Birt-Hogg-Dub\u00e9 syndrome. Br J Cancer 122: 590-594, 2020.","DOI":"10.1038\/s41416-019-0693-1"},{"key":"30","unstructured":"30. Zbar B, Alvord WG, Glenn G, et al. Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dub\u00e9 syndrome. Cancer Epidemiol Biomarkers Prev 11: 393-400, 2002."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/18\/64_4985-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T03:28:46Z","timestamp":1758338926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/18\/64_4985-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":30,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4985-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"article-number":"4985-24"}}